CHRU Besançon

Besançon 25030

0 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, Early Breast Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Locally Advanced Pancreatic Cancer, Metastatic Pancreas Cancer, Non-Alcoholic Steatohepatitis (NASH), Obesity, Overweight, Pancreatic Adenocarcinoma, Peritoneal Cancer

Studies at this site

• A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy — Running, not enrolling
• A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression — Completed
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed
• A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer — Completed
• Phase 2b Study in NASH to Assess IVA337 — Completed
• EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX — Completed